Concepedia

Vilma Decman

VD

Statistics

Publications

10

Citations

872

H-Index

10

Active since

2005

Affiliations

Regeneron (United States)(Current)

United States Food and Drug Administration

GlaxoSmithKline (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

AstraZeneca (United States)

Vilma Decman is an author at Regeneron (United States) specializing in life sciences, immunology, and cd8 positive t cells.

ORCID

Publications per year

2005–2024

10

Publications

10

C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice

Amanda Atanasio, Vilma Decman, Derek W. R. White et al. · Scientific Reports · 2016 · 265 citations · Full text

, , +17

Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity

Brian J. Laidlaw, Vilma Decman, Mohammed A. Ali et al. · PLoS Pathogens · 2013 · 150 citations · Full text

, , +17

Gamma Interferon Can Block Herpes Simplex Virus Type 1 Reactivation from Latency, Even in the Presence of Late Gene Expression

Vilma Decman, Paul R. Kinchington, S. Harvey et al. · Journal of Virology · 2005 · 140 citations · Full text

, , +17

Defective CD8 T Cell Responses in Aged Mice Are Due to Quantitative and Qualitative Changes in Virus-Specific Precursors

Vilma Decman, Brian J. Laidlaw, Travis A. Doering et al. · The Journal of Immunology · 2012 · 138 citations · Full text

, , +17

Cell-Intrinsic Defects in the Proliferative Response of Antiviral Memory CD8 T Cells in Aged Mice upon Secondary Infection

Vilma Decman, Brian J. Laidlaw, Lauren J. DiMenna et al. · The Journal of Immunology · 2010 · 73 citations · Full text

, , +17

1–5 of 10